Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy

ConditionSpinocerebellar Ataxia - All Sub-types

Trial statusNot yet recruiting

Trial phasePhase 1, Phase 2

Trial typeInterventional

Biological sexAll

Age18-45

SponsorBiocells Medical

About this trial

This clinical study aims to evaluate the safety and preliminary therapeutic potential of mesenchymal stem cell-derived therapies in patients diagnosed with spinocerebellar palsy. The investigational treatment includes neuroinduced mesenchymal stem cells and their derived exosomes administered via intravenous and intranasal infusion.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Intrathecal infusion
Intranasal infusion

Treatment groups

90 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Biocells Medical

Lead sponsor

Source ClinicalTrials.gov